Scientists have identified a possible tipping point in the brain's immune cells that may help explain why some people with Alzheimer's pathology stay sharp while others develop dementia.
The research
Researchers from VIB, KU Leuven, the UK-Dementia Research Institute, and Muna Therapeutics — with funding that included support from the European Research Council — analyzed donated brain tissue from older adults with and without cognitive decline, plus samples from cognitively healthy centenarians. The findings were published in Nature Medicine.
The team combined spatial transcriptomics and single-cell sequencing to examine tissue at the level of individual cells. This let them map six distinct tissue domains representing different stages of Alzheimer's progression. One key transition separated regions dominated by amyloid-β plaques from those tied to tau pathology and neurodegeneration.
That shift came with a major change in microglia, the brain's resident immune cells. Early in the disease process, microglia entered an inflammatory state linked to amyloid plaques. Later, they moved into an antigen-presenting state that appeared alongside tau pathology. Antigen presentation is how immune cells display molecular material to coordinate an immune response. This change may mark a biological turning point that helps decide whether Alzheimer's pathology proceeds toward brain cell damage and dementia.
Resilience looked different across groups. Octogenarians with amyloid plaques but no dementia showed the early microglial response — but their microglia did not shift into the later immune state associated with progression. Centenarians took a different route: their brains activated the later microglial program, but largely without it being tied to tau accumulation.
"The study, entirely based on human donor material, provides insight into one type of resilience mechanism in the progression of AD to dementia," said Prof. Bart De Strooper of the VIB-KU Leuven Center for Neuroscience, an ERC grantee and co-senior author.
Why it matters
Alzheimer's affects more than 55 million people worldwide, and it is commonly associated with amyloid-β plaques and tau tangles. But these biological signs do not always match a person's mental condition. Some people accumulate substantial plaques and tangles yet remain cognitively healthy. This research shifts attention from how much pathology is present to how brain cells respond to it — and suggests people can resist Alzheimer's-related damage through more than one biological pathway. For anyone tracking their own cognitive health, it is a reminder that brain resilience is an active biological process, not just the absence of disease markers.
What you can do
- Keep challenging your brain with varied tasks — novelty and complexity support cognitive reserve.
- Stay physically active and manage cardiovascular risk factors, which influence brain health.
- Prioritize sleep, since it supports the brain's waste-clearing systems.
- Track your own cognition over time with objective, repeatable measures rather than one-off impressions.
Source: ScienceDaily Mind & Brain
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.